202 related articles for article (PubMed ID: 9884908)
1. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia.
Sinclair AJ; Bayer AJ; Johnston J; Warner C; Maxwell SR
Int J Geriatr Psychiatry; 1998 Dec; 13(12):840-5. PubMed ID: 9884908
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.
Krishnan S; Rani P
Biol Trace Elem Res; 2014 May; 158(2):158-65. PubMed ID: 24682919
[TBL] [Abstract][Full Text] [Related]
3. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease.
Foy CJ; Passmore AP; Vahidassr MD; Young IS; Lawson JT
QJM; 1999 Jan; 92(1):39-45. PubMed ID: 10209671
[TBL] [Abstract][Full Text] [Related]
4. Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients.
Hatanaka H; Hanyu H; Fukasawa R; Hirao K; Shimizu S; Kanetaka H; Iwamoto T
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():53-8. PubMed ID: 26671158
[TBL] [Abstract][Full Text] [Related]
5. Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia.
Polidori MC; Mattioli P; Aldred S; Cecchetti R; Stahl W; Griffiths H; Senin U; Sies H; Mecocci P
Dement Geriatr Cogn Disord; 2004; 18(3-4):265-70. PubMed ID: 15286458
[TBL] [Abstract][Full Text] [Related]
6. [Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease].
Polidori MC; Stahl W; De Spirt S; Pientka L
Dtsch Med Wochenschr; 2012 Feb; 137(7):305-8. PubMed ID: 22318842
[TBL] [Abstract][Full Text] [Related]
7. Transcranial and extracranial ultrasound assessment of cerebral hemodynamics in vascular and Alzheimer's dementia.
Doepp F; Valdueza JM; Schreiber SJ
Neurol Res; 2006 Sep; 28(6):645-9. PubMed ID: 16945217
[TBL] [Abstract][Full Text] [Related]
8. Mismatch negativity as a potential neurobiological marker of early-stage Alzheimer disease and vascular dementia.
Jiang S; Yan C; Qiao Z; Yao H; Jiang S; Qiu X; Yang X; Fang D; Yang Y; Zhang L; Wang L; Zhang L
Neurosci Lett; 2017 Apr; 647():26-31. PubMed ID: 28336337
[TBL] [Abstract][Full Text] [Related]
9. Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia.
Bernardi F; Lanzone A; Cento RM; Spada RS; Pezzani I; Genazzani AD; Luisi S; Luisi M; Petraglia F; Genazzani AR
Eur J Endocrinol; 2000 May; 142(5):466-71. PubMed ID: 10802523
[TBL] [Abstract][Full Text] [Related]
10. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias.
Casado A; Encarnación López-Fernández M; Concepción Casado M; de La Torre R
Neurochem Res; 2008 Mar; 33(3):450-8. PubMed ID: 17721818
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients.
Bourdel-Marchasson I; Delmas-Beauvieux MC; Peuchant E; Richard-Harston S; Decamps A; Reignier B; Emeriau JP; Rainfray M
Age Ageing; 2001 May; 30(3):235-41. PubMed ID: 11443025
[TBL] [Abstract][Full Text] [Related]
12. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
[TBL] [Abstract][Full Text] [Related]
13. Ultrasonographic measurement of cerebral blood flow, cerebral circulation time and cerebral blood volume in vascular and Alzheimer's dementia.
Schreiber SJ; Doepp F; Spruth E; Kopp UA; Valdueza JM
J Neurol; 2005 Oct; 252(10):1171-7. PubMed ID: 16151603
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting.
Sicras A; Rejas J; Arco S; Flores E; Ortega G; Esparcia A; Suárez A; Gordillo MJ
Dement Geriatr Cogn Disord; 2005; 19(5-6):305-15. PubMed ID: 15785031
[TBL] [Abstract][Full Text] [Related]
15. The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls.
Famulari AL; Marschoff ER; Llesuy SF; Kohan S; Serra JA; Dominguez RO; Repetto M; Reides C; Sacerdote de Lustig E
J Neurol Sci; 1996 Sep; 141(1-2):69-78. PubMed ID: 8880696
[TBL] [Abstract][Full Text] [Related]
16. Peripheral 8-iso-PGF2α as a Biomarker in Bosnian Patients with Alzheimer's Disease and Vascular Dementia.
Lepara O; Zaciragic A; Fajkic A; Dzubur Kulenovic A; Dervisevic A; Valjevac A; Kiseljakovic E; Ibragic S
Psychiatr Danub; 2020; 32(3-4):389-394. PubMed ID: 33370737
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of coenzyme Q10 in patients with Alzheimer's disease.
de Bustos F; Molina JA; Jiménez-Jiménez FJ; García-Redondo A; Gómez-Escalonilla C; Porta-Etessam J; Berbel A; Zurdo M; Barcenilla B; Parrilla G; Enriquez-de-Salamanca R; Arenas J
J Neural Transm (Vienna); 2000; 107(2):233-9. PubMed ID: 10847562
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
Allan LM; Ballard CG; Burn DJ; Kenny RA
J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine, antioxidant vitamins and lipids as biomarkers of neurodegeneration in Alzheimer's disease versus non-Alzheimer's dementia.
Raszewski G; Chwedorowicz R; Chwedorowicz A; Gustaw Rothenberg K
Ann Agric Environ Med; 2016; 23(1):193-6. PubMed ID: 27007541
[TBL] [Abstract][Full Text] [Related]
20. Oxidative balance, homocysteine, and uric acid levels in older patients with Late Onset Alzheimer's Disease or Vascular Dementia.
Cervellati C; Romani A; Seripa D; Cremonini E; Bosi C; Magon S; Passaro A; Bergamini CM; Pilotto A; Zuliani G
J Neurol Sci; 2014 Feb; 337(1-2):156-61. PubMed ID: 24321755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
